NAVIDEA BIOPHARMACEUTICALS I (NAVB)

US63937X2027 - Common Stock

0.0779  0 (-2.99%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
65.65K531.51K915.01K657.83K1.17M
Minority Interest Expense
0.000.000.0020.00380.00
Cost Of Goods
184.95K0.001.05K6.67K96.64K
Gross Profit
-119.30K531.51K913.96K651.16K1.07M
Operating Expenses
13.93M12.59M11.63M11.61M11.92M
Research and Development
5.97M5.14M4.93M5.34M4.22M
Selling, General, and Administrative Expenses
7.87M7.37M6.62M6.13M7.55M
Operating Income
-14.05M-12.06M-10.71M-10.96M-10.85M
Interest Income/Expense
-1.10M-6.36K11.34K25.29K-30.80K
Other Income/Expense
-27.94K-14.12K-21.85K-7.61K1.15K
Non Recurring Items
0.00366.00KN/A0.00-5.29M
Income Before Taxes
-15.18M-11.71M-10.72M-10.94M-16.17M
Income Tax
0.0016.04K0.00710.00-9.75K
Net Income
-17.22M-11.73M-11.39M-10.95M-16.11M
EBITDA
-13.96M-11.98M-10.64M-10.82M-10.70M
 
Per Share Data
EPS Diluted Total Ops
-0.56-0.40-0.48-0.76-1.90
Non GAAP EPS
N/A-0.40-0.48-0.80N/A
 
Statistics
Gross Profit Margin
-181.72%100.00%99.89%98.99%91.74%
Profit Margin
-26222.45%-2207.09%-1244.31%-1664.29%-1378.03%
Operating Profit Margin
-21402.74%-2269.09%-1170.61%-1666.47%-927.64%

All data in USD

Charts